Stay updated on Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedAdded a new version entry on 2026-07-31 with a Study Status note linked to 2026-07-30 and the value 90. Removed the 2026-07-13 entry from the history.SummaryDifference0.2%

- Check9 days agoChange DetectedThe page's revision label in the footer was updated to v3.6.4, replacing the previous v3.6.3 to reflect a new deployment.SummaryDifference0.0%

- Check16 days agoChange DetectedA new version entry (89) appears around 2026-07-10/13, adding the 'Study Status' and 'Study Identification' sections, and the 2026-06-05 entry was deleted.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe footer now displays Revision: v3.6.3, replacing v3.6.2, indicating a new site release was deployed.SummaryDifference0.0%

- Check38 days agoChange DetectedFooter now shows Revision: v3.6.2, replacing the previous v3.6.0. This reflects a newer platform release behind the scenes.SummaryDifference0.0%

- Check52 days agoChange DetectedThe record now shows 'No longer looking for participants', indicating recruitment has ended, and the revision has been updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.